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Abstract
The metabolism of arginine towards ATP synthesis has been considered a major source of energy for microorganisms such
as Mycoplasma penetrans in anaerobic conditions. Additionally, this pathway has also been implicated in pathogenic and
virulence mechanism of certain microorganisms, i.e. protection from acidic stress during infection. In this work we present
the crystal structures of the three enzymes composing the gene cluster of the arginine deiminase pathway from M.
penetrans: arginine deiminase (ADI), ornithine carbamoyltransferase (OTC) and carbamate kinase (CK). The arginine
deiminase (ADI) structure has been refined to 2.3 A˚ resolution in its apo-form, displaying an ‘‘open’’ conformation of the
active site of the enzyme in comparison to previous complex structures with substrate intermediates. The active site pocket
of ADI is empty, with some of the catalytic and binding residues far from their active positions, suggesting major
conformational changes upon substrate binding. Ornithine carbamoyltransferase (OTC) has been refined in two crystal
forms at 2.5 A˚ and 2.6 A˚ resolution, respectively, both displaying an identical dodecameric structure with a 23-point
symmetry. The dodecameric structure of OTC represents the highest level of organization in this protein family and in
M.penetrans it is constituted by a novel interface between the four catalytic homotrimers. Carbamate kinase (CK) has been
refined to 2.5 A˚ resolution and its structure is characterized by the presence of two ion sulfates in the active site, one in the
carbamoyl phosphate binding site and the other in the b-phosphate ADP binding pocket of the enzyme. The CK structure
also shows variations in some of the elements that regulate the catalytic activity of the enzyme. The relatively low number
of metabolic pathways and the relevance in human pathogenesis of Mycoplasma penetrans places the arginine deiminase
pathway enzymes as potential targets to design specific inhibitors against this human parasite.
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Introduction
Mycoplasmas belong to the class Mollicutes, a widely distributed
group of microorganisms evolved from Gram-positive bacteria by
a reduction in their genomes. The loss of genetic information
related to metabolic activities and biosynthetic capabilities for
essential compounds has emphasized the parasitic mode (of life) of
all known Mycoplasma species, with each specie usually showing a
strict host and tissue specificity [1]. Mycoplasma penetrans is a human
parasite which persistently colonizes the respiratory and urogenital
tracts invading and surviving within infected cells [2]. Lacking a
complete tricarboxylic acid cycle and cytochromes, most molli-
cutes obtain ATP mainly through glycolysis and fermentative
metabolism of carbohydrates. However, some Mycoplasma species
are nonglycolytic or nonfermentative, and for them arginine
catabolism has been considered, though not conclusively estab-
lished, as the major source of energy [3]. In these cases, arginine
degradation is done by means of the arginine deiminase (ADI)
pathway, an anaerobic route found in Bacteria [4], Archaea [5],
and amitochondrial Eukarya [6–8]. In mycoplasmas, the ADI
pathway varies at the genomic level, ranging from the complete
absence of all the genes in some species, to their presence, even
though not necessarily functional, in others [9]. In this regard, M.
penetrans possesses and expresses the complete set of the ADI
pathway genes at the same time while exhibiting a fermentative
metabolism.
The ADI pathway is composed by three catalytic enzymes:
arginine deiminase (ADI, EC 3.5.3.6), ornithine carbamoyltrans-
ferase (OTC, EC 2.1.3.3) and carbamate kinase (CK, EC 2.7.2.2).
This pathway performs the conversion of arginine to ornithine,
ammonia, CO2 and ATP, yielding one mole of ATP per mole of
arginine. ADI catalyzes the first step of the argininine degradation
pathway, the deimination of arginine, producing citrulline and
ammonium. Subsequently, OTC processes citrulline and uptakes
inorganic phosphate to generate ornithine and carbamoyl
phosphate. OTC enzymes can also be anabolic and catalyze the
reverse reaction. The anabolic OTC can synthesize citrulline to be
utilized in the arginine biosynthetic pathway or in the urea cycle.
In this sense, some organisms, such as Pseudomonas aeruginosa,
encode different OTCs genes dedicated to either the ADI pathway
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or to the arginine biosynthetic pathways [4,10,11]. In the last step
of the ADI pathway, CK catalyzes the hydrolysis of the carbamoyl
phosphate to CO2 and ammonia, while the phosphate group is
used to phophorylate ADP to generate ATP. Similarly to OTCs,
in some organisms such as Pyrococcus furiosus, CK can catalyze the
opposite reaction synthesizing carbamoyl phosphate from carba-
mate and ATP [12].
The absence of the arginine deiminase gene (ADI) in the human
genome, and the presence and importance of it in pathogenic
protozoa like Giarda intestinalis [13,14] and pathogenic bacteria like
Pseudomonas aeruginosa [15–17] (primarily infecting immuno-com-
promised patients [18]), make the ADI enzyme an attractive
therapeutic target for some parasitic and bacterial infections.
Additionally, ADI might represent a potential tumor growth
inhibitor [19–22]. ADI structures and reaction mechanisms have
been described in detail in Pseudomonas aeruginosa [23,24] and
Mycoplasma arginini [25]. In the present work we have resolved the
structure of ADI from Mycoplasma penetrans at 2.3 A˚, and
comparison to previous substrate-bound structures of ADI from
M.arginini reveals substantial structural rearrangements in the
active site of the enzyme upon binding of the substrate.
As previously mentioned, OTC (ornithine carbamoyltransfer-
ase) can be both anabolic or catabolic in some microorganisms
[10,26], possessing different genes for both catabolic and anabolic
reactions, such as in P. aeruginosa. The anabolic reaction is related
to the arginine biosynthesis in plants and to the urea cycle in the
mitochondria in mammals [27,28]. OTC is closely related to the
aspartate transcarbamoylase (ATCase, EC 2.1.3.2) [29], a well-
known example of an allosteric enzyme in the biosynthesis of
pyrimidine. All transcarbamylases or carbamoyltransferases share
the same basic overall protein fold which contains two domains: a
CP-binding domain (carbamoyl phosphate binding domain) and
an amino acid binding domain. The basic quaternary structure
organization is a homotrimer, with the active site located at the
interface between monomers [30,31]. OTC proteins have a wide
average range of quaternary structures, the most basic form being
a homotrimer [32]. However, in some cases, such as Lactobacillus
hilgardii, the quaternary assembly is an homohexamer, containing
two homotrimers [33]. Additionally, a dodecameric assembly
containing four homotrimers has been observed in the catabolic
OTC of P.aeruginosa [31] and in the hyperthermophilic Pyrococcus
furiosus [34]. Dodecameric assemblies of OTCs have been
suggested to be involved in thermophilic resistance or in allosteric
enzyme regulation by cooperativity [31,35,35]. The two crystal
structures of OTC from Mycoplasma penetrans described in this work
possess a quaternary dodecameric assembly, which, despite a
similar organization, is unique to Mycoplasma penetrans at the
interface between the catalytic homotrimers and contain particular
interactions.
Carbamate kinase (CK) generates ATP from carbamoyl
phosphate and ADP, and this constitutes the last step in the
fermentative catabolism of arginine, agmatine and allantoin/
oxalurate [4,36–40]. The absence of this protein in animals and its
importance in generating energy in some pathogenic microorgan-
isms like Giardia intestinalis or Trichomonas vaginalis makes CK an
attractive therapeutic target [7,41]. Structures of CK bound to
ADP and to sulfate ions have already been described in two
different organisms, Enterococcus faecalis and Pyrococcus furiosus [42–
44], and in both cases there was a substantial structural
rearrangement upon binding of substrates. The structure here of
CK from M.penetrans differs from the previous structures by the
presence of two sulfate ions, one in the carbamoyl phosphate
pocket and another in the b-phosphate ADP binding pocket.
Particularly interesting in the M.penetrans CK structure described
here, is the ‘‘open’’ and non-catalytic conformation of the PSD
subdomain, despite the presence of a sulfate ion in the carbamoyl
phosphate-binding pocket.
Results
Protein expression and purification
The expression of arginine deiminase (ADI) from the pET-19b
recombinant plasmid as described in Methods produced mostly
insoluble protein. Transcription analysis of the M. penetrans arc
operon, performed by primer extension, indicates the existence of
two transcription start sites (unpublished results), giving rise upon
translation, to the above described long-ADI and to a short-ADI
form initiating at Met43 and ending at Lys452. Remarkably,
pairwise and clustal alignments between ADI sequences from
different Mycoplasma species and from M. penetrans start around
Met43 residue of the short ADI-form, leaving N-terminal
extensions (i.e., residues 1–42) without alignment in relation to
the homologous sequences. To check if the recombinant
expression of short-ADI would overcome the solubility problems
encountered with long-ADI, the corresponding coding sequence
was amplified from plasmid pBE-arcA by using adi-7 and adi-6 as
forward and reverse primers, respectively (see Table S1). The 59-
end of adi-7 primer also bears an NdeI restriction site, allowing the
cloning of the amplified short-ADI coding sequence into the pET-
19b expression vector, as described for the long-ADI form. The
same protein purification protocol described in Methods was
applied to the short-ADI form. The recombinant production of
short-ADI substantially improved from the production of the full
length or long-ADI form in terms of both expression yields and
solubility. Gel filtration of short-ADI, as expressed in E.coli,
indicated the formation of a dimer, probably representing the
biological unit of the protein. The final protein yield was 4 mg of
recombinant ADI per liter of culture.
Recombinant production of full-length M. penetrans OTC in
E.coli yielded a high level of expression, and the protein was easily
purified by Ni2+-affinity interaction through the N-terminal His-
tag from the pET-19b vector. Gel filtration chromatography of
recombinant OTC indicated the presence of high molecular
oligomerization forms, probably corresponding to a dodecameric
structure, although other lower molecular weight oligomers could
also be isolated. The final protein yield was 15 mg of recombinant
OTC per liter of culture. Full-length carbamate kinase (CK) was
also produced in E.coli in high yields and subsequently purified by
Ni2+-affinity chromatography. Recombinant M. penetrans CK also
eluted from the gel filtration column mainly as a dimer, suggesting
that such a form might also correspond to the biological unit of the
enzyme. The final protein yield was 6 mg of recombinant CK per
liter of culture.
Before attempting the crystallization studies, the functionality of
the three purified enzymes was tested by performing specific
activity assays [45]. Activity data of ADI, OTC, and CK measured
from crude cell extracts of M. penetrans, compared to the enzymes
expressed in E. coli, allowed us to conclude that the obtained
recombinant proteins behave as their native counterparts (data not
shown).
Crystal structure of arginine deiminase (ADI) from
Mycoplasma penetrans
The polypeptide chain of ADI can be clearly and completely
traced in the electron density maps from Gly54 to Lys452
(Figure S1). Crystals of M.penetrans ADI display a large unit cell
composed of twelve molecules in the asymmetric unit. All the
molecules in the asymmetric unit display a similar structure, with
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an rms deviation of 0.25 A˚ for the mainchain. Based on results
obtained by gel-filtration chromatography, the biological unit can
be considered to be a dimer (making up 6 dimers in the
asymmetric unit). Structural alignment software (PDBefold) shows
homology with the only other two known ADI structures, from
Mycoplasma arginini (PDB code 1LXY) and from Pseudomonas
aeruginosa (PDB code 1RXX). These structures display rms
deviations with M.penetrans ADI of 1.54 A˚ and 1.85 A˚, for 391
and 360 aligned residues with a pair-wise sequence identity, of
59% and 28%, respectively.
The overall protein fold and the secondary structure elements
found in previous ADI structures are conserved in M.penetrans and
consist of the repetition of a three-stranded mixed b sheet and a
helix forming five bbab modules in a cyclical arrangement
(Figure S1). This 5-fold pseudosymmetric moiety is also charac-
teristic of other arginine-catabolizing enzymes such as Arg:Gly
amidinotransferase (AT, [46]; PDB code 1JDW), dimethylarginine
dimethylaminohydrolase (DDAH, [47]; PDB code 1H70) and
agmatine deiminase (AgDI, [48]; PDB code 2JER). This
characteristic protein fold seems to have evolved to interact and
catalyze reactions containing guanidinium substrates, such as
arginine. In the case of the arginine deiminase enzymes (ADI), this
5-fold pseudosymmetric a/b modular domain also contains an
additional 85-residue a-helical domain between the first and
second module (helices a4 to a8, see Figure S1). The role of this
five-helix bundle domain, that is absent in the AT, DDAH and
AgDI structures, is still not clear, but it has been speculated that it
can participate in the activation of processes such as apoptosis
[25].
The active site of the enzyme is located approximately at the
center of the structure, forming a buried and compact substrate-
binding pocket. Previous structures of M.arginini ADI in a covalent
complex with two L-arginine substrate intermediates ([25]; PDB
code 1LXY and 1S9R) defined the binding pocket and the
catalytic residues of the enzyme. In our apo-form structure of ADI
from M.penetrans, all the substrate binding residues for the
enzymatic reaction are conserved, but need to undergo substantial
structural rearrangements to carry out the catalytic reaction. The
apo-form ADI structure of M.penetrans would correspond to the
‘‘open’’ conformation of the enzyme, whereas the intermediate-
substrate bound ADI structure of M.arginini would represent the
‘‘closed’’ conformation (Figure 1). As observed for many enzymes
that follow an induced-fit mechanism, the occurrence of ‘‘open’’
and ‘‘closed’’ conformations are necessary to permit the correct
catalytic reaction, which allows for the entrance and the release of
the substrate and end product, respectively.
In the intermediate-bound ADI structure from M.arginini (PDB
code 1LXY), the amino and carboxylate groups of the arginine
substrate establish polar and charged interactions with Leu44,
Asn155, Arg180, Arg232 and Gly392 (Leu88, Asn198, Arg223,
Arg276 and Gly434 in the M.penetrans numbering). In our apo-
form structure of M.penetrans ADI, the carbonyl groups of Leu88
and Gly434 are moved 2 A˚ away from their binding positions with
the amino group of the arginine substrate, whereas Asn198 is
located in a similar position. Arg223 and Arg276 (M.penetrans
numbering), which bind the carboxylate group of the arginine
substrate, undertake substantial movements of approximately 4 A˚
(particularly for Arg276) from their positions in the ‘‘open’’ to the
‘‘closed’’ conformations (Figure 1). The fixation of the aliphatic
moiety of the arginine substrate is established by hydrophobic
interactions with the Phe158 and Met268 sidechains (Phe201 and
Met312 in the M.penetrans numbering). Comparison between the
‘‘closed’’ and our apo-form of M.penetrans ADI (‘‘open’’ confor-
mation) indicates that, whereas Phe201 does not move from its
location, Met312 needs to move approximately 3 A˚ to interact
with the substrate during the catalytic reaction.
The catalytic reaction of the ADI enzyme is performed by the
catalytic triad composed of Cys440, His313 and Glu257, where
the sulfur of Cys440 catalyzes a nucleophilic attack on the
guanidino carbon of the arginine substrate. The role of Asp204
and Asp315 is also crucial for the stabilization of the tetrahedral
intermediates during the catalytic reaction, as observed in the two
intermediate complexes of ADI from Mycoplasma arginini and
Pseudomonas [24,25]. In our ‘‘open’’ conformation of M.penetrans
ADI, Cys440 is located in a similar position as in the ‘‘closed’’
conformation, whereas His313 and Glu257 need to move about 3
A˚ to interact with the arginine substrate. Asp204 and Asp315 also
move in this conformation, albeit to a lesser degree (Figure 1).
Therefore, it is essentially the movement of three loops
containing some of the catalytic and binding residues of the active
site pocket that is needed to switch from the ‘‘open’’ to the
‘‘closed’’ conformation of the enzyme, namely the loops a9-b5,
b6-a10 and b7-a11 (Figure 1B). These three ‘‘mobile’’ loops are
essentially shaping one side of the active site pocket, whereas the
other side does not seem to undertake any substantial rearrange-
ment upon substrate binding. A similar substrate induced-fit
mechanism from the ‘‘open’’ to the ‘‘closed’’ conformation has
also been previously described for the Pseudomonas aeruginosa ADI
[23,24], which has a 28% sequence identity with the ADI from
Mycoplasma. Interestingly, a notable difference in the P.aeruginosa
apo-form of ADI is the presence of an arginine residue, which
corresponds to Met435 in M.penetrans, which is located in the
middle of the active site pocket forming a salt bridge with an
aspartate residue. This interaction needs to be disrupted and the
arginine side chain displaced from the active site to allow the
binding of the substrate. This does not occur in the Mycoplasma
ADI and might be a reason for the large disparity in affinities for
the substrate binding displayed by two orders of magnitude
difference in the Km constant [24].
Crystal structure of ornithine carbamoyltransferase (OTC)
from Mycoplasma penetrans
Two different crystal forms of the OTC from M.penetrans have
been refined. The first one belonged to the P213 space group and
was refined to 2.6 A˚, and the second one belonged to a P321 space
group and was refined to 2.5 A˚. In both crystal forms the
polypeptide chain of M.penetrans OTC can be clearly and
completely traced in the electron density maps (from Met1 to
Tyr342). The asymmetric unit of M.penetrans OTC is composed of
four molecules in both crystals forms, displaying an average rms
deviation of 0.35 A˚ between the four molecules. Structural
alignment server (PDBefold) shows high homology with many
OTC structures deposited in the PDB data bank, being the top
ones from Pseudomonas aeruginosa (PDB code 1DXH) and from
Escherichia coli (PDB code 1AKM). These structures display rms
deviations compared with M.penetrans OTC of 1.26 A˚ and 1.21 A˚,
for 328 and 309 aligned residues with a sequence identity of 47%
and 46%, respectively.
Despite the different space groups of the two crystal forms, in
both cases an identical dodecameric quaternary structure was
observed with an exact 23 point-group symmetry. In the two
crystal forms this dodecameric structure was predicted by the
PISA server (http://www.ebi.ac.uk/msd-srv/prot_int/pistart.
htlm) and might correspond to the biological unit of the protein.
The elution time in the gel filtration purification of the
recombinant M.penetrans OTC also corresponds to the formation
of a dodecameric quaternary structure. In most cases the
oligomeric structure of OTC corresponds to a homotrimer, which
Structures of the Arginine Deiminase Pathway
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represents the catalytic unit of the enzyme [32]. Only three OTCs
have been reported to possess a similar dodecameric quaternary
structure as M.penetrans, OTCs from Pseudomonas aeruginosa ([31];
PDB code 1ORT), Pyrococus furiosus ([34]; PDB code 1ALS) and
Thermotoga maritima (PDB code 1VLV; only deposited). Remark-
ably, two of them are thermophiles, suggesting a potential role of
the quaternary compact structures in high temperature protection
in those environments. In all cases the dodecamer structure is
formed by the interaction of four homotrimers disposed in a
tetrahedral manner [34,49,50]. The four three-fold symmetry
axes, located at the vertexes of the tetrahedral, are perpendicular
to the center of the opposite homotrimer, and the three two-fold
symmetry axes pass through the middle of opposite edges.
The trimeric structure of OTC is conserved in all known
structures of OTCs and represents the catalytic unit of the
enzyme, displaying one active site per monomer (Figure S2). As
with all other known OTCs structures, the monomer consists of
two domains of approximately similar size, the carbamoyl
phosphate-binding domain (or polar domain, residues 1–150)
and the ornithine-binding domain (or equatorial domain, residues
151–320). Each domain is named according to their respective
involvement in substrate recognition. The secondary structure of
each domain is made up of a five-stranded parallel b-sheet
surrounded by a-helices, with helices a5 and a14 of M.penetrans
OTC linking the two domains (Figure S2). The active site is
located in a cleft formed between the two domains, and by
comparison with other OTC structures, residues from both
domains are involved in the catalytic reaction. By comparison
with OTC structures bound to substrate analogs [51,52], the
relative positions of residues binding the carbamoyl phosphate
moiety are mainly conserved in the M.penetrans OTC, including the
positive pocket shaped by Ser59, Thr60, Arg61, Thr62, Arg110,
His137, Gln140 and Arg328 (M.penetrans OTC numbering).
Structural comparison between the apo- and the substrate-bound
forms of OTCs [51,52] indicate that the carbamoyl phophate-
binding domain displays less flexibility than the ornithine-binding
Figure 1. Conformational changes on the ADI structures upon substrate binding. (A) Stereo view representation of the superposition of
the open active-site of Mycoplasma penetrans ADI (yellow) with closed active-site of the Mycoplasma arginini ADI in complex with arginine (white).
ADI residues involved in the substrate binding and catalysis are labeled and shown in stick representation. (B) Stereo view ribbon representation of
the superposition between the Mycoplasma penetrans ADI (yellow) with the Mycoplasma arginini ADI in complex with arginine (blue). Three major
mobile loops of the ADI structure are labeled.
doi:10.1371/journal.pone.0047886.g001
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domain, in which larger structural rearrangements are induced
during the catalytic reaction. Thus, whereas the catalytic patch
formed by residues His275, Cys276 and Leu277 does not vary its
position between the apo- and the substrate-bound forms in the
ornithine-binding domain [51,52], the loop between Trp237 and
Phe247 displays a different conformation in the apo form of the
M.penetrans OTC. Interestingly, this loop constitutes the main
binding site for ornithine and is formed by the conserved
DxxxSMG motif (between b8 and a10) in all OTC structures,
except in our structure of M.penetrans OTC, in which methionine is
substituted by leucine. The movement of this SMG-loop seems to
be essential for binding of the second substrate and product release
during the catalytic reaction [51].
The interfaces between monomers within the catalytic homo-
trimer are located mainly within the carbamoyl phosphate-binding
domain, and are basically formed by the a2 helix and part of the
last a14 helix that interacts with the region formed by the b2
strand and the a3 helix from the adjacent monomer (Figure S2).
Analysis of the quaternary structure of the homotrimer structures
of M.penetrans OTC (PISA server) displays a buried average
interface of 590 A˚2 between monomers. Each monomer contrib-
utes 60 residues to the interface, including 12 hydrogen bonds and
9 salt bridges. The total buried surface in the homotrimer structure
is 1750 A˚2 (indicating an energetically favorable formation of the
homotrimer that constitutes the catalytic unit) with some of the
interface residues as part of the active site.
The interface between homotrimers that constitute the
dodecameric structure is mainly located at the four 3-fold
symmetry axes at the vertices of the tetrahedron (Figure 2). This
interface is mainly formed by three a1 helices and the loop
between a1 and b1 from three monomers from the different
catalytic trimers located around each 3-fold symmetry axes. The
interface between two monomers buries approximately 330 A2
that would represent a total of 990 A2 for each 3-fold symmetry
axes interaction. Each monomer contributes 35 residues to the
interface, mainly consisting of the aforementioned a1 helix
residues, but with additional residues from the N- and C-terminal
regions. Quaternary structure analysis by the PISA server indicates
that the interface between two monomers contains 5 hydrogen
bonds and 4 salt bridges. In Figure 2 the interface between
homotrimers is located around the threefold symmetry axis at one
top of the dodecamer. In the M.penetrans OTC dodecamer, this
interface forms an intermolecular network of hydrogen bonds
between Asn42 and Asn43 from the three monomers, which is
unique to the sequence of M.penetrans OTC (Figure 2C).
Interestingly, the four known dodecameric structures of OTC
(including the M.penetrans OTC) display completely different
chemical profiles of the residues involved in the three-fold
interface and only the relative positions of the main chain atoms
can be superimposed. In the case of the P.furiosus OTC, the
interaction around the threefold symmetry axis is mainly
hydrophobic (Figure 2E), presenting major interactions between
Met29, Trp33 and Lys38 [34]. In the case of the P.aeruginosa OTC,
the threefold symmetry axis interface is basically charged and
polar (Figure 2D), with major contribution of Arg28, Arg32,
Thr39 and Gln41 [31]. The fourth dodecamer structure of an
OTC is that of Thermotoga maritima (PDB code 1VLV; only
deposited), and in this case the threefold symmetry axis interface
presents a mixture of polar and hydrophobic interactions
(Figure 2F). These different interfaces produce minor shifts and
rotations between homotrimers in the global quaternary structure
arrangement when a catalytic trimer is superimposed within the
dodecamer.
In the case of P.furiosus, and perhaps in T.maritima, the
domecameric quaternary structure has been involved in the
extreme thermal stability of these microorganisms. It has been
suggested that the thermophilic properties of the P.furiosus OTC
are, in part, the result of the hydrophobic interfaces between
homotrimers [49,50]. In the case of P.aeruginosa, the dodecameric
structure was first directly involved in the allosteric mechanism of
the enzyme, which displays a marked cooperativity for carbamoyl
phosphate [31], although it was later found than OTC homo-
trimers could also retain such cooperativity [53,54]. In any case,
the presence of higher oligomerization structures might be linked
to an increase in the efficiency of the reaction in the ADI pathway,
by means of thermal protection or by quaternary structure-
induced cooperativity. Interestingly, a tunnel mechanism between
OTC and the next catabolic enzyme of the ADI pathway,
carbamate kinase (CK), has been suggested, as a means to protect
from high temperatures and to efficiently transfer the labile
(relatively unstable) product of the OTC reaction, carbamoyl
phosphate [55].
Crystal structure of carbamate kinase (CK) from
Mycoplasma penetrans
The polypeptide chain of the M.penetrans CK can be traced in
the electron density maps from Arg3 to Ser133 and from Lys157
to Ala309 (Figure S3). The gap in the electron density maps
corresponds to the flexible PSD domain (‘‘Protruding SubDo-
main’’), and only residues at both ends of the PSD domain and the
internal loop from Ala143 to Val150 could be partially modeled in
the electron density, all displaying high temperature B-factors and
giving as a result a poor agreement between Rwork and the Rfree in
the final refined structure. Crystals of M.penetrans CK display a unit
cell composed of one molecule in the asymmetric unit. Based on
results obtained by gel-filtration chromatography, by predictions
of the PISA server and by previous structures of CK from other
organisms, the biological unit can be considered to be a dimer.
Structural alignment server PDBefold shows strong homology with
the other known CK structures, such as CK from Pyrococcus furiosus
(PDB code 1E19), from Giardia lamblia (PDB code 2KZF) and from
Enterococcus faecalis (PDB code 2WE5). These structures display rms
deviations with M.penetrans CK of 1.23 A˚, 1.59 A˚ and 1.54 A˚, for
279, 266 and 271 aligned residues with sequence identities of 43%,
37% and 41%, for P.furiosus, G.lamblia and E.faecalis, respectively.
The overall protein fold and the secondary structure elements
are conserved in M.penetrans CK and basically consist of a central
eight-stranded parallel b-sheet, with six strands parallel in one
orientation and two strands in an opposite orientation (b12 and
b14), surrounded by a-helical elements at both sides of the central
b-sheet (Figure S3). As previously described for the first CK
structures from E.faecalis and P.furiosus [42,43], the structure can be
divided in two domains, with a large crevice in the middle that
creates the binding sites for the two substrates, carbamoyl
phosphate (CP) and ADP. The N-terminal domain (residues
Met1 to Ala222), rich in a-helices, is composed by two sets of four
stranded b-sheets, the first sheet constituted by four parallel
strands from the central b-sheet and the second sheet smaller and
formed by mixed b-strands. This domain contains three long a-
helices, a1, a2 and a3, which make up the entire dimer interface,
and the mobile PSD domain (‘‘protruding subdomain’’, from
Lys126 to Val159), which is involved in the catalytic reaction by
an overall ‘‘rigid body’’ movement upon substrate binding. The C-
terminal domain (residues Asp223 to Ala309) is smaller and
formed by the four mixed b-strands from the central b-sheet,
surrounded by three a-helices. Whereas the binding residues for
carbamoyl phosphate basically emanate from the N-terminal
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domain, the C-terminal domain is responsible for the binding of
ADP. Interestingly, in our structure of M.penetrans CK, two sulfate
ions from the crystallization buffer might be present in the b- and
c-phosphate-binding pockets of the synthesized ATP product
molecule, with only present in such position in the CK structures
from E.faecalis (PDB codes 2WE4 and 2WE5).
In our current structure of M.penetrans CK, the location of some
of the residues that have been suggested to contact the phosphate
group of the carbamoyl phosphate substrate (CP) are conserved.
These are the sidechain of Lys209 and the amino backbone
nitrogens of Gly10, Asn11, Gly47, and Gly48. However, the
putative coordination of the phosphate group of CP shown for the
E.faecalis CK is not complete in M.penetrans, since the sidechain of
Lys126 (Lys128 in the structure of the E.faecalis CK), which
belongs to the mobile PSD domain, is not interacting with the
sulfate ion. Interestingly, the inferred position of the PSD domain
in the M.penetrans CK is in an ‘‘open’’ orientation, more similar to
the E.faecalis CK-ADP bound structure (PDB code 2WE5) than to
the E.faecalis CK-SO4-bound structure (PDB code 2WE4)
(Figure 3). In our M.penetrans CK structure, the PSD domain can
only be partially traced in the electron density maps, with all atoms
displaying high values of temperature B-factors, indicating a strong
tendency of this domain to shift between different conformations.
The PSD domain has been postulated to act as a ‘‘rigid body’’ that
is triggered upon the binding of the CP molecule to allow the
catalytic reaction [43]. However, in our M.penetrans CK structure,
despite the presence of a sulfate ion occupying a similar CP
binding site as in the E.faecalis CK-SO4-bound (PDB code 2WE4),
Figure 2. OTC dodecamer structure and the threefold interface between homotrimers. (A) Ribbon representation of the Mycoplasma
penetrans OTC dodecamer. Each monomer is shown with a different colour. (B) Surface view of the M. penetrans OTC dodecamer. Each homotrimer is
shown with a different color. (C, D, E, F) Stereo ribbon representation of the threefold interface between homotrimers. Residues involved in the
dodecamer assembly are labeled and shown in stick representation for different species; (C) Mycoplasma penetrans, (D) Pseudomonas aeruginosa, (E)
Pyrococcus furiosus, (F) Thermotoga maritima.
doi:10.1371/journal.pone.0047886.g002
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the PSD domain displays an ‘‘open’’ conformation, not productive
for the phosphoryl transfer of the carbamoyl phosphate to the
ADP molecule.
The second sulfate ion found in the M.penetrans CK structure is
located approximately in a similar position as the b-phosphate of
the ADP molecule observed in the E.faecalis and P.furiosus CK-
ADP bound structures ([42,43]; PDB codes 2WE5 and 1E19,
respectively). Mimicking the ADP b-phosphate, the second sulfate
ion interacts with the side chains of Lys271, Thr229 and the
amino backbone nitrogen of Ala230. In our M.penetrans CK
structure this sulfate ion is also at contact distance with the
sidechain of Asn11 (3.24 A˚), adopting the b1-a1 loop in a
conformation similar to the CK-SO4-bound E.faecalis structure
(PDB code 2WE5). Interestingly, the sidechain of Asn11 can
potentially interact with both sulfate ions in our structure, the
putative b-phosphate and mobile c-phosphate of ATP, suggesting
a participation of this residue in bridging the transfer of the
phosphoryl group during the reaction of the enzyme. The other
regions in the structure that might interact with the ADP molecule
are in the ‘‘open’’ conformation, as observed in the CK-SO4-
bound structure (PDB code 2WE5). These observations support
the plasticity observed in most of the active-site regions of enzymes
to allow catalysis and release of the end products.
In summary, the M.penetrans CK structure bound to two sulfate
ions displays some differences in comparison to previous structures
(CK-ADP from E.faecalis and P.furiosus; and CK-SO4 from
E.faecalis). In the M.penetrans CK structure, despite the CP binding
site being occupied by a sulfate ion, the PSD domain adopts an
‘‘open’’ orientation, which differs from the ‘‘closed’’ orientation
observed in the CK-SO4 complex structure from E.faecalis, in
which a sulfate ion occupies a similar position or in the G.lamblia
CK structure ([56]; PDB code 3KZF), in which a glycerol
molecule occupies the putative CP binding site. The orientation of
the PSD domain in the M.penetrans CK resembles the PSD
domains in the CK ADP-bound structures from E.faecalis and
P.furiosus, but in both cases without any sulfate ions in the CP
binding site (Figure 3D).
The movement of the PSD domain between an ‘‘open’’ and
‘‘closed’’ orientation to interact with the CP molecules has been
described to be essential for the catalytic mechanism of the
phosphoryl transfer between CP and ADP, allowing the interac-
tion of the sidechain of Lys126 with CP molecule [43]. In our
M.penetrans CK structure, the ‘‘open’’ orientation of the PSD
domain with a sulfate ion occupying the CP binding site has not
been observed, and might represent a structural snapshot of the
binding of CP before the enzymatic reaction occurs. However/
likewise, it could also be an example of the product complex before
the release of the CP from the active site in the anabolic reaction of
synthesis of the carbamoyl phosphate from carbamate [42].
Similarly, the binding of the second ion sulfate at the b-phosphate
position of the ADP molecule indicates the strong binding
tendency of this region to interact with charged ions (sulfates or
phosphates). Remarkably, in a previous E.faecalis CK sulfate-
bound structure, this second binding site pocket was not occupied
by any sulfate ion.
Conclusions
The arginine deiminase pathway (ADI) is the most widespread
anaerobic route for arginine degradation in microorganisms and
performs the conversion of arginine to ornithine, ammonia, and
CO2, generating one mole of ATP per mole of arginine consumed.
The ADI pathway constitutes an important source of energy in
some microorganisms and like many other enzymatic pathways, it
is also organized in a gene cluster to better regulate and optimize
the production of the proteins. Here we have described the
structure of the three enzymes that constitute the gene cluster in
the ADI pathway in Mycoplasma penetrans (together with the specific
membrane-associated arginine permease coded by arcD gene) and
compared them to previous structures of the enzymes. Arginine
deiminase (ADI), which catalyzes the first step in the ADI
pathway, have been crystallized in its apo-form, and differs from
the previous substrate-bound structures of Mycoplasma arginini by
displaying an ‘‘open’’ conformation of the active site. The second
enzyme of the pathway is ornitine transcarbamylase (OTC), which
can catalyze the reaction in both directions and displays a
dodecameric structure in the two crystal forms that have been
crystallized. Dodecameric organization of OTC has been
described in three microorganisms, P.aeruginosa, P.furiosus and
T.maritima, in other organisms homotrimers can be found as the
usual oligomeric form of this enzyme. Interestingly, the interfaces
that form the OTC dodecamer in all these organisms are
completely different, not showing any sequence homology between
them and displaying either charged or hydrophobic interactions in
the 3-fold symmetry axes of the dodecamer. Our current structure
of M.penetrans OTC shows a novel interface forming the
dodecamer. The last enzyme of the pathway is the carbamate
kinase (CK), which is responsible for the formation of new
molecules of ATP from carbamoyl phosphate. The crystal
structure of CK contains two sulfate ions in the active site pocket,
mimicking the binding of the b- and c-phosphate of the ATP
product molecule before the phosphorylation reaction has
occurred. Interestingly, in our CK structure the position of the
mobile PSD domain is in an ‘‘open’’ and non-catalytic conforma-
tion, despite the CP binding site being occupied by a sulfate ion,
and might represent a structural snapshot of the binding of the
substrates before the catalytic reaction occurs. The structural
characterization of the enzymes of the ADI pathway in Mycoplasma
penetrans has shed light to particular features of these proteins that
eventually might provide new tools to interfere in the growing and
proliferation of this pathogenic organism in humans.
Methods
Gene cloning and mutagenesis
A 3749-bp fragment (namely ArcABC) containing the genes for
arginine deiminase (arcA), ornithine carbamoyltransferase (arcB),
and carbamate kinase (arcC) was isolated from Mycoplasma penetrans
GTU-54 strain (kindly provided by J. Baseman, University of
Texas, San Antonio, USA) genomic DNA by PCR amplification
using the set of primers Arc1penetr (forward) and Arc2penetr
Figure 3. Conformational changes on the CK structures upon substrate binding. (A) Stereo view representation of the superposition of the
active site of CK from Mycoplasma penetrans (yellow) and Enterococcus faecalis (ligth blue). Sulfate ions are shown in stick representation. CK residues
involved in the substrate binding and catalysis are labeled and shown in stick representation. (B) Stereo view ribbon representation of the
superposition of the CK from Mycoplasma penetrans (yellow) and Enterococcus faecalis (ligth blue). Sulfate ions are shown in stick representaion. (C)
Stereo view representation of the superposition of the active site of CK from Mycoplasma penetrans (yellow) and from Enterococcus faecalis in
complex with ADP (light blue). Sulfate ions and ADP molecule are shown in stick representation. CK residues involved in the substrate binding and
catalysis are labeled and shown in stick representation. (D) Stereo view ribbon representation of the superposition of the CK from Mycoplasma
penetrans (yellow) and Enterococcus faecalis (ligth blue) in complex with ADP.
doi:10.1371/journal.pone.0047886.g003
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(reverse); see Table S1 for their respective sequences. The
ArcABC fragment was blunt-end cloned into the EcoRV site of
plasmid vector pBE, a derivative of pBSKII (Stratagene, CA) in
which the multicloning site has been removed and substituted by a
single EcoRV site [57]; the recombinant plasmid pBE-ArcABC
was transformed into E. coli XL1-Blue strain. TGA is a stop codon
in the universal genetic code but mycoplasmas translate such a
codon as a tryptophan. Therefore, before attempting the
heterologous expression in E. coli of mycoplasma gene products,
any TGA in a coding region should be changed to TGG in order
to incorporate the native Trp residue into the corresponding
polypeptide. The arcA gene of M. penetrans contains two TGA
codons that code for Trp317 and Trp339 in the arginine
deiminase (ADI) amino acid sequence; equally, the arcB gene
contains two TGA codons that code for Trp129 and Trp237 in the
ornithine carbamoyltransferase (OTC). On the contrary, arcC gene
coding for carbamate kinase (CK) does not contain any TGA
codon. TGA codons were changed to TGG by site-directed
mutagenesis, performing for each gene (arcA and arcB) six
consecutive PCR steps, as outlined in Figure S4. The different
couples of primers for each PCR reaction (numbered 1–6) and
each gene (ADI and OTC) are indicated in Table S1, along with
the length (in base pairs) of the amplified fragment. Mutagenic
primers correspond to numbers 2, 3, 4, and 5; moreover, primers 2
and 4 are fully complementary to primers 3 and 5, respectively,
and include the same point mutations (indicated with a bold
character in Table S1). Phusion DNA polymerase (New England
Biolabs) and 2 mM MgCl2 were used in all PCR reactions. Briefly,
using the pBE-ArcABC recombinant plasmid as a template, a first
PCR (PCR1 in Figure S4) amplifies from the start codon of the
corresponding coding sequence to the first TGA codon to be
mutated; a second PCR (PCR2) amplifies from the first TGA
codon to the second one; and, finally a third PCR3 amplifies from
the second TGA to the stop codon of the coding sequence. Next,
using primers 1 and 4 and as DNA template the products of PCR1
and PCR2 reactions, PCR4 allowed to amplify from the start
codon to the second TGA (already changed to TGG); in the same
way, with the use of primers 3 and 6 and PCR2 plus PCR3
products as templates, PCR5 amplifies from the first TGA (TGG)
to the stop codon. Note that PCR1, PCR2, and PCR3 products
overlap at the ends including the mutated TGA codons (see
Figure S4). Finally, the complete gene incorporating both changed
TGG codons was obtained with PCR6 by using primers 1 and 6
and PCR4+PCR5 reaction products as templates; in this case, the
complementary overlapping sequence between both PCR prod-
ucts corresponds to the DNA region expanding from the first to
the second TGG. Not being necessary to change any TGA codon,
the arcC gene was directly amplified from pBE-ArcABC using the
corresponding primers 1 and 6 (ck-1 and ck-6 in Table S1,
respectively). The products of the three PCR6 reactions (corre-
sponding to arcC, and the mutated arcA and arcB genes) were
cloned into the EcoRV site of the pBE vector and the recombinant
plasmids pBE-ArcA, pBE-ArcB, and pBE-ArcC were transformed
into E. coli XL1-Blue strain. For each gene, three independent
clones were sequenced. Sequencing reactions with fluorescent
dideoxynucleotides were performed using the Big Dye 3.0
Terminator kit (Applied Biosystems) following the manufacturer’s
instructions and analyzed in an ABI 3100 Genetic Analyzer
(Applied Biosystems). The substitution of TGA by TGG codons
was confirmed in the arcA and arcB genes, and no other change
with regard to the native sequences (including the arcC gene) was
observed.
Protein expression and purification
For the recombinant expression of individual proteins, TGA
mutated arcA (long-ADI, see below), arcB, and arcC genes were
cloned into pET-19b plasmid vector (Novagen) as follows.
Mutated genes were excised from the corresponding pBE
derivative (see above) by digestion with NdeI and BamHI restriction
enzymes, whose recognition sequences were borne by the 59-end
of PCR primers 1 and 6, respectively (underlined in Table S1).
The NdeI-BamHI fragments were ligated to pET-19b expression
vector, previously linearized with the same restriction enzymes,
allowing the fusion of a His10-tag coding sequence to the 59-end of
each gene. Finally, the obtained recombinant plasmids were
transformed into E. coli host expression strain BL21 (DE3).
Cells were grown at 37uC in Luria–Bertani (LB) growth
medium supplemented with ampicillin (50 mg/L) to an optical
density at 600 nm of 0.9 for ADI expression or 0.7 for OTC and
CK expression. Protein expression was then induced by addition
of 1 mM isopropyl b-D-1-thiogalactopyranoside (IPTG) to the
culture medium, followed by shaking at 37uC for 3 hours. Induced
cells were harvested by centrifugation, and resuspended in 5 mM
imidazole, 0.5 M NaCl, 20 mM Tris-HCl (pH 7.9) (namely
Binding Buffer), containing 1 mM phenylmethanesulfonyl fluoride
(PMSF). Cells were disrupted by sonication, and the insoluble
material removed by centrifugation at 400006g for 20 minutes;
supernatants were recovered and passed through a 0.45 mm filter.
The histidine-tagged recombinant proteins were purified by
loading the supernatants onto Hi-Trap Chelating Sepharose (GE
Healthcare) chromatography columns equilibrated in Binding
Buffer. Columns were washed with 60 mM imidazole, 0.5 M
NaCl, 20 mM Tris-HCl (pH 7.9), and His-tagged retained
proteins were eluted with 1 M imidazole, 0.5 M NaCl, 20 mM
Tris-HCl (pH 7.9). Fractions containing the eluted proteins were
pooled, dialyzed against 50 mM NaCl, 20 mM Tris–HCl (pH 8.0)
buffer, and then loaded onto a HiLoad Superdex 200 26/60 gel-
filtration column (GE Healthcare) previously equilibrated with the
same buffer, as a final polishing purification step. Eluted fractions
were analyzed by SDS-PAGE, and the purest samples were
pooled, frozen in liquid-N2, and stored at 280uC. Protein
concentration was estimated by the Coomassie-binding method
of Bradford, using bovine serum albumin as a standard.
Crystallization and data collection
Crystals of arginine deininase (ADI) were obtained at 18uC by
sitting drop vapor diffusion methods. The reservoir solution
contained 0.9M Trisodium citrate, 0.1M Sodium cacodylate pH
6.5. Single crystals appeared after 2 days from equal volumes of
protein solution (5 mg/ml in 5 mM Tris pH 8.0, 50 mM NaCl)
and reservoir solution. Crystals of ornithine carbamoyltransferase
(OTC) were grown at 18uC by sitting drop vapor diffusion
methods in two different reservoir conditions: in 0.2M ammonium
acetate, 39% MPD, 0.1M tri-sodium citrate pH 5.5 (trigonal space
group) and in 15% PEG20000 and 0.1M MES pH 6.5 (cubic
space group). Crystals of carbamate kinase (CK) were obtained at
18uC by sitting drop vapor diffusion methods in a reservoir
condition with 1.8M ammonium sulfate, 2% PEG400, 0.1M
HEPES pH 7.0. All crystals were cryo-protected in reservoir buffer
containing 12% glycerol and flash-frozen in liquid nitrogen prior
to diffraction analysis. Diffraction data were recorded from cryo-
cooled crystals (100K) at Grenoble beamline ID23-2. Data were
integrated and merged using XDS [58] and scaled, reduced and
further analyzed using CCP4 [59] (Table 1).
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Structure determination and refinement
The structure of ADI was determined from the x-ray data by
molecular replacement using the PDB from Mycoplasma arginini
(PDB code 1S9S) as a model. The two structures of OTC were
determined from the x-ray data by molecular replacement using
the PDB from Pseudomonas aeruginosa (PDB code 1DXH) as a
model. The structure of CK was determined from the x-ray data
by molecular replacement using the PDB from Enterococcus faecalis
(PDB code 2WE5) as a model. The initial electron density maps
produced from molecular replacement programs were manually
improved to build up complete models for ADI, OTC and CK
using the program COOT [60]. Model refinement was performed
with CNS [61] and Phenix [62]. ADI contained 12 molecules in
the asymmetric unit and the Ramachandran analysis shows
95.36% of residues (4543) are in preferred regions, 4.47% of
residues (213) are in allowed regions and 0.17% of residues (8) are
in outlier regions. OTC crystal 1 contained four molecules in the
asymmetric unit and the Ramachandran analysis shows 94.71% of
residues (1288) are in preferred regions, 4.41% of residues (60) are
in allowed regions and 0.88% of residues (12) are in outlier
regions. OTC crystal 2 also contained four molecules in the
asymmetric unit and the Ramachandran analysis shows 94.34% of
residues (1283) are in preferred regions, 4.34% of residues (59) are
in allowed regions and 1.32% of residues (18) are in outlier
regions. CK contained one molecule in the asymmetric unit and
the Ramachandran analysis shows 90.88% of residues (259) are in
preferred regions, 7.37% of residues (21) are in allowed regions
and 1.75% of residues (5) are in outlier regions. Refinement and
data statistics are provided in Table 1. Structural representations
were prepared with PyMOL [63].
Accession codes
Protein Data Bank: Coordinates and structure factors from the
three structures were deposited in the PDB data with accession ID
codes 4E4J (MpADI), 4AMU (MpOTC), 4ANF (MpOTC) and
4AXS (MpCK).
Supporting Information
Figure S1 ADI structure and sequence alignment. (A)
Ribbon representation of the ADI structure from Mycoplasma
penetrans. The a-helix and b- strands are represented in red and
golden, respectively, and are labeled sequentially from N-
terminus. (B) Surface representation of ADI from M.penetrans. AS
indicates the active site pocket. (C) Surface representation of ADI
from M.arginini (PDB code) in complex with arginine in the active
site (colored in magenta). AS indicates the active site pocket. (D)
Topology-based sequence alignment of ADI from Mycomplasma
penetrans, Mycoplasma arginini and Pseudomonas aeruginosa. The
secondary structural elements are labelled and shown above the
sequence as rectangles or arrows for a-helix and b-strands,
respectively. Active site residues are colored in red. Identical or
highly conserved residues are highlighted in yellow.
(PDF)
Figure S2 OTC structure and sequence alignment. (A)
Ribbon representation of the structure of the OTC monomer from
Mycoplasma penetrans. The a-helix and b-strands are represented in
Table 1. Data collection and refinement statistics.
Data Collection ADI OTC (crystal 1) OTC (crystal 2) CK
Space group P21 P321 P213 P3221
Cell dimensions
a, b, c (A˚) 120.5, 128.8, 220.3 183.6, 183.6, 117.3 167.9, 167.9, 167.9 51.8, 51.8, 174.2
a, b, c (u) 90, 91.4, 90 90, 90, 120 90, 90, 120 90, 90, 120
Resolution (A˚)a 30–2.3 (2.40– 2.30) 49–2.5 (2.64–2.50) 50–2.6 (2.74–2.60) 45–2.38 (2.51–2.38)
Rmerge
b 0.060 (0.367) 0.090 (0.436) 0.094 (0.367) 0.068 (0.388)
I/sI 9.8 (2.0) 12.1 (2.6) 8.7 (2.4) 11.8 (2.5)
Completeness (%) 97.6 (96.1) 98.2 (89.7) 98.6 (95.4) 97.7 (92.2)
Redundancy 1.9 (1.9) 4.8 (3.4) 2.4 (2.3) 4.8 (4.5)
Refinement
Resolution (A˚) 30–2.3 49–2.5 48–2.6 45–2.5
No. Reflections 288889 74328 47453 9819
Rwork/Rfree
c 21.60/24.23 17.01/21.51 17.9/23.9 23.19/28.68
No. Atoms 39631 11190 11035 2558
No. aa protein 4788 1376 1368 309
Water 1615 418 339 33
R.m.s deviations
Bond lengths (A˚) 0.007 0.008 0.009 0.008
Bond angles (u) 1.33 1.154 1.206 1.155
PDB code 4E4J 4AMU 4ANF 4AXS
aStatistic for highest resolution shell is shown in parentheses.
bRmerge = g |Ii 2 , I .|/g Ii , where Ii is the ith measurement of the intensity of an individual reflection or its symmetry-equivalent reflections and ,I. is the average
intensity of that reflection and its symmetry-equivalent reflections.
cRwork = g ||Fo| 2 |Fc||/g |Fo| for all reflections and Rfree = g ||Fo| 2 |Fc||/g |Fo|, calculated based on the 5% of data excluded from refinement.
doi:10.1371/journal.pone.0047886.t001
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red and golden, respectively, and are labeled sequentially from the
N-terminus. Residues involved in the active-site are shown in stick
representation. (B) Ribbon representation of the OTC homotrimer
structure. (C) Topology-based sequence alignment of OTC from
Mycoplasma penetrans, Pseudomonas aeruginosa, Themortoga maritima,
Pyrococcus furiosus, Lactobacillus hilgardii, Gleobacter violacius and
Escherichia coli. The secondary structural elements are labeled
and shown above the sequence as rectangles or arrows for a-
helices or for b- strands, respectively. Active site residues are
colored in red. Identical or highly conserved residues are
highlighted in yellow.
(PDF)
Figure S3 Structure of the CK from M. penetrans and
sequence alignment. (A) Ribbon representation of CK from
Mycoplasma penetrans. The a-helix and b-strands are represented in
red and golden, respectively, and are labeled sequentially from the
N-terminus. Residues involved in the active-site are shown in stick
representation. (B) Ribbon representation of the dimer of CK. In
one of the monomers, the N-terminal domain is in colored in light
blue, the C-terminal domain in forest green and the PSD domain
in lime green. The two sulfate ions are shown in stick
representation. (D) Topology-based sequence alignment of CK
from Mycoplasma penetrans, Enterococcus faecalis, Pyrococcus furiosus and
Giardia lamblia. The secondary structural elements are labeled and
shown above the sequence as rectangles or arrows for a- helices or
forb-strands, respectively. Active site residues are colored in red.
Identical or highly conserved residues are highlighted in yellow.
(PDF)
Figure S4 Mutagenesis strategy. Scheme illustrating the
strategy followed to change the two TGA, coding for tryptophan
in M. penetrans, by TGG codons before the heterologous expression
of arcA (ADI) and arcB (OTC) genes in E. coli. Numbered arrows
indicate the primers (see Table S1 for primer sequences and
features). The successive six PCR amplifications carried out are
also indicated. Cloning of arcC gene, which does not contain any
TGA codon, was performed in a single reaction (PCR6) using
primers 1 and 6.
(PDF)
Table S1 Primers. Underlining indicates the restriction sites
introduced at the 59 end of selected primers. A bold lowercase
character indicates the changed base in mutagenic primers.
(PDF)
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